Clinical Trials Browser

Phase 1/2 × Gastric and Gastroesophageal Junction Adenocarcinoma × pembrolizumab × Clear all

NCT05508737 2025-07-11

Pembrolizumab and Trifluridine/Tipiracil With Previously Treated Advanced Gastric Cancer

Phase 1/2 Active not recruiting

Gastrointestinal

Gastric and Gastroesophageal Junction Adenocarcinoma